The Alzheimer's Association revised the diagnostic criteria for Alzheimer disease (AD) and ADRD for clinicians in primary and specialty care.

Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.

A strategic approach to AI can help provide businesses with the tools they need to future-proof operations and drive ...

Certain drugs and a host of nonpharmacologic therapies are key to treating patients who have nociplastic pain, a relatively ...

All biological function is dependent on how different proteins interact with each other. Protein-protein interactions facilitate everything from ...

Researchers have been trying to find new ways to produce and replicate the various useful features observed in nature. Fine ...

Dive into the world of AI agent authentication, where cutting-edge security meets autonomous systems. Discover how delegation ...

The HUMANOID Center at UC San Diego is pioneering organoid research aimed at improving the reliability and reproducibility of ...

A new study published in the Journal of Affective Disorders shows that individuals with depression exhibit slower and less ...

Spinraza treatment does not lead to significant kidney dysfunction in SMA patients with types 1 and 2, a safety and efficacy ...

The evolution of functional assessments for spinal muscular atrophy (SMA) highlights the challenges of adapting pediatric ...

Cognitive functional therapy may reduce disability and pain among patients with chronic LBP and neck pain compared with other interventions.